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lathrin provides an external scaffold to form small
50–100-nm transport vesicles. In contrast, for-
mation of much larger dense-cored secretory gran-
ules is driven by selective aggregation of internal cargo at
the trans-Golgi network; the only known role of clathrin
in dense-cored secretory granules formation is to remove
missorted proteins by small, coated vesicles during
maturation of these spherical organelles. The formation
of Weibel-Palade bodies (WPBs) is also cargo driven,
but these are cigar-shaped organelles up to 5 
 
 
 
m long.
C
 
We hypothesized that a cytoplasmic coat might be required
to make these very different structures, and we found
that new and forming WPBs are extensively, sometimes
completely, coated. Overexpression of an AP-180 trun-
cation mutant that prevents clathrin coat formation or
reduced AP-1 expression by small interfering RNA both
block WPB formation. We propose that, in contrast to
other secretory granules, cargo aggregation alone is not
sufﬁcient to form immature WPBs and that an external
scaffold that contains AP-1 and clathrin is essential.
 
Introduction
 
Weibel-Palade bodies (WPBs) are the large secretory organelles,
which can be up to 5 
 
 
 
m long, of endothelial cells. They are
uniquely “cigar-shaped”—typically cylindrical with hemi-
spheric ends (Weibel and Palade, 1964; Wagner, 1990; Hannah
et al., 2002; Michaux and Cutler, 2004). Their best understood
components are the hemostatic protein von Willebrand factor
(VWF; Sakariassen et al., 1979; Wagner et al., 1982; Sad-
ler, 1998; Ruggeri, 1999) and the integral membrane protein
P-selectin (Bonfanti et al., 1989; McEver et al., 1989). Regu-
lated exocytosis of WPBs delivers VWF and P-selectin to the
cell surface where they act in the recruitment of platelets and
leukocytes. WPBs thus play a vital role in acute inflammation and
in formation of the primary hemostatic plug. P-selectin–deficient
mice have delayed neutrophil extravasation upon injury (Mayadas
et al., 1993; Subramaniam et al., 1997), whereas the commonest
inherited human bleeding disorder, von Willebrand’s disease,
largely results from mutations in VWF (Wagner, 1990; Nichols
and Ginsburg, 1997; Sadler, 1998). The biogenesis of secreta-
gogue-responsive WPBs is therefore of prime physiological
importance, and their unusual shape has always implied that
this process may be complex but little is known of the mecha-
nisms involved.
Protein content is thought to play an important part in
secretory granule biogenesis, driving the formation of these
organelles by selective aggregation at the TGN (for review see
Thiele and Huttner, 1998) to form their dense proteinaceous
core. One of the most dramatic demonstrations of cargo-driven
biogenesis follows the heterologous expression of VWF, which
triggers the formation of pseudo-WPBs in nonendothelial and,
even, nonsecretory cells (for review see Michaux et al., 2003).
Not only are the structures formed in this way indistinguishable
from bona fide WPBs at the EM level, but they also recruit
WPB-resident membrane proteins and undergo exocytosis in
response to secretagogue stimulation.
Cytoplasmic coat complexes act structurally during
formation of vesicles and also help select membrane and con-
tent proteins for inclusion. Clathrin and the clathrin-associated
adaptor protein complex AP-1 have been reported to act on
immature secretory granules (ISGs) during granule maturation.
In rat endocrine pancreatic 
 
 
 
 cells, AP-1/clathrin-coated vesi-
cles (CCVs) remove missorted mannose 6-phosphate receptors
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from ISGs (Klumperman et al., 1998). In neuroendocrine PC12
cells, the protein convertase furin and the mannose 6-phosphate
receptor are also removed from ISGs via AP-1 CCVs (Dittie et
al., 1999). The removal of missorted proteins and the gradual
condensation of the protein content are major elements of the
maturation of secretory granules (for reviews see Arvan and
Castle, 1998; Tooze et al., 2001). Are AP-1 and clathrin in-
volved in the formation of WPBs?
EM analysis of human umbilical vein endothelial cells
(HUVECs) revealed extensive coating of newly formed and
forming perinuclear WPBs. Coverage of WPBs by visible coats
along the long axis for up to 650 nm and complete coating of
WPBs up to 150 nm in diameter have been observed. We used
immunofluorescence to show that this coat contains clathrin
and AP-1, the latter further confirmed by immuno-EM. Reduc-
ing the ability of AP-1 and clathrin to function by anti–AP-1
RNA interference (RNAi) or a dominant-negative AP180 con-
struct, which prevents the inclusion of clathrin into forming
coats, does not, as might be expected from the previous work
on secretory granules mentioned in the previous paragraph,
lead to the accumulation of missorted proteins within WPBs,
but instead to a failure to form WPBs at all. Our results provide
the first evidence that coat proteins can also play an essential
role in the initial formation of a secretory granule rather than
only during their maturation.
 
Results
 
WPBs are coated
 
By conventional transmission EM of ultrathin sections from
epon-embedded HUVECs, WPBs appear as cigar-shaped
membrane-bound organelles with internal VWF tubules (stria-
tions in longitudinal sections) that make up the bulk of their
content. Interestingly, we found that some WPBs are exten-
sively, possibly even completely, covered with a proteinaceous
coat (Fig. 1, a and b). The scale of the coverage is remarkable,
given the size of WPBs. At least part of the coat has a bristle-
like structure, resembling clathrin. Fig. 1 c shows a similar coat
surrounding the transverse section of a small immature WPB
(arrowhead), which was identified based on its size and the
characteristic granular appearance of the content protein. VWF
tubules are occasionally visible in transverse sections of WPBs
(Fig. S3 a, available at http://www.jcb.org/cgi/content/full/
jcb.200503054/DC1), depending on the angle of sectioning.
The presence of a typical CCV (Fig. 1 c, arrow) within this sec-
tion emphasizes by comparison the scale and extent of coating
seen on WPBs. CCVs, including those involved in ISG matura-
tion, are 50–100 nm in diameter. To cover the small WPBs in
the top of Fig. 1 b, one would need at least 20 times more clath-
rin than is required to coat a conventional CCV. Immunofluo-
rescence studies on HUVECs revealed partial colocalization of
VWF and clathrin (Fig. 1 e) in structures that are clearly cigar
shaped and that are associated with TGN46. The electron mi-
crograph in Fig. 1 d shows a WPB with partial coating at an
area where the VWF tubules are less structured. This might
correspond to the VWF-containing structures (Fig. 1 e, right,
arrowheads) that are partially coated with clathrin. The more
extensive coating seen in the electron micrographs, as com-
pared with the immunofluorescence, presumably reflects the
use of glutaraldehyde in addition to PFA in the EM fixative.
Our data suggests that at least some WPBs are completely cov-
ered, implying a structural role for this coat, rather than it sim-
ply being required to remove missorted proteins via conven-
tional CCVs.
Our EM analyses also revealed that WPBs in the perinu-
clear part of the cell are more often coated than those in the pe-
Figure 1. Perinuclear WPBs are coated. (a–d) Conventional
transmission EM of HUVECs shows extensive coating of
WPBs. Bars, 200 nm. (a) Arrowheads point to the coat covering
a WPB. (b) Such coating is more often observed in the peri-
nuclear region (arrowheads). (c) A transverse section of a
WPB (arrowhead) and a typical CCV (arrow) have different
diameters. (d) Partial coating (arrowhead) on a WPB is seen
where the VWF tubules are less structured. (e) Newly emerging
WPBs at the TGN (arrowheads) in two different cells partially
colocalize with clathrin by immunofluorescence. Bar, 10  m. 
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riphery. Fig. 1 b shows two coated WPBs that are in close
proximity to the nucleus. We previously showed that newly
formed WPBs are found in this region, often as a distinctly lo-
cated tangle of cigars, separated from the older, more generally
distributed population (Hannah et al., 2003). This distribution
for newly formed WPBs is in agreement with a TGN origin
for these organelles, as are the cigar-shaped VWF-positive
TGN46-positive structures that appear to be attenuated exten-
sions of the TGN (Fig. 1 e, arrowheads). These observations
suggest that the coat might play a role in the early stages of
WPB formation.
The identification of clathrin on WPBs immediately
raises the question of which specific coat components might be
present. This is of importance both in its own right but also be-
cause the ability to manipulate a specific component of this
coat in functional experiments (see the following section) re-
duces the possibility of any effects arising from an indirect ef-
fect of losing clathrin function, as clathrin is involved in multi-
ple trafficking pathways. Immunofluorescence analyses of
HUVECs reveal that AP-1 is found predominantly on perinu-
clear WPBs (Fig. 2, a–e), consistent with the EM localization
of coated WPBs (Fig. 1). The AP-1 staining is present in
patches along the whole length of the WPBs. We therefore pos-
tulate that the coat on WPBs may be labile and transient, in
agreement with our need to increase levels of PFA in the fixa-
tive to 6% to obtain more consistent labeling. Immuno-EM of
cryosections of HUVECs with anti–AP-1 and anti-VWF con-
firmed the presence of AP-1 on the surface of WPBs (Fig. 2, g
and h, arrowheads). The relative size of coated WPBs (arrow-
heads) and CCVs (arrows) in Fig. 2 g is comparable with that
in Fig. 1 c.
 
Clathrin and AP-1 are essential for WPB 
biogenesis
 
To study the role of clathrin and AP-1 in the formation of new
WPBs, we expressed human full-length VWF in human embry-
onic kidney (HEK293) cells, which leads to the formation of
pseudo-WPBs. These behave similarly to endothelial WPBs:
they have a cigar-shaped structure and contain internal VWF tu-
bules, recruit P-selectin, CD63, and Rab27a, and are capable of
regulated secretion (Michaux et al., 2003). This model system
enables us to avoid the possibility of preexisting WPBs masking
any effects of our experiments on the formation of new WPBs
and to carry out quantitative VWF secretion analyses without
any background from WPBs made before manipulation.
To examine the role of clathrin in WPB formation, we re-
duced the functional pool of clathrin in HEK293 cells by ex-
pressing an AP180 construct (AP180-C; Ford et al., 2001)
which contains a clathrin-binding domain and has a dominant-
negative effect on clathrin function. If the only role of clathrin
is to retrieve missorted proteins during the maturation of WPBs
as in conventional ISG biogenesis (Introduction), we would ex-
pect to find immature WPBs containing mislocalized proteins
in AP180-C/VWF–cotransfected HEK293 cells. Surprisingly,
no cigar-shaped WPBs at all are found in these cells (Fig. 3, a
and b) but instead VWF localized to fine puncta (Fig. 3 b). To
examine the functional significance of this altered morphology,
we examined the constitutive and secretagogue-stimulated re-
lease of VWF from VWF-expressing HEK293 cells that had
been cotransfected with AP180-C or a control plasmid. The
cells were rinsed and incubated in serum-free medium (serum
contains VWF) without any secretagogue for 30 min, and then
with medium containing the secretagogue PMA for 30 min fur-
ther. Culture media were collected after each 30-min incuba-
tion and ELISA-based assays were performed for VWF quanti-
fication. The PMA-responsive pool of VWF was estimated by
subtracting the amount of VWF released by constitutive secre-
tion from that released upon PMA addition. The data were ex-
pressed as a percentage of the total VWF signal (see Materi-
als and methods). In AP180-C–transfected HEK293 cells, we
found a significant reduction in regulated secretion of VWF
(Fig. 4 a). The increase in fine VWF-positive puncta (Fig. 3 b)
correlating with the raised level of constitutive VWF secretion
(Fig. 4 a) suggests that these might be constitutive secretory
vesicles. Upon coexpression of VWF and AP180-C, some cells
expressed VWF but not AP180-C, which may explain the small
residual pool of PMA-responsive VWF.
To determine the functional significance of AP-1 in WPB
biogenesis, we performed RNAi on HEK293 cells using a small
Figure 2. AP-1 is present on WPBs. (a–e) Partial colocalization of AP-1 and
VWF shown by immunofluorescence. HUVECs were fixed in 6% PFA, per-
meabilized, and labeled with mouse anti–AP-1 and rabbit anti-VWF, fol-
lowed by FITC-conjugated anti–mouse and Texas red–conjugated anti–
rabbit secondary antibodies. Bars, 10  m. (a) A perinuclear WPB is
substantially covered with AP-1. The insets show a higher magnification of
the boxed area (top inset, AP-1; bottom inset, VWF). (b–e) Further examples
of partial colocalization of VWF (b and d) and AP-1 (c and e). (f–h) Immuno-
EM of HUVEC cryosections show the presence of AP-1 on WPBs. Bars, 200
nm. (f) A WPB labeled with rabbit anti-VWF followed by 15 nm gold parti-
cles conjugated to protein A. (g) AP-1 is observed on CCVs (arrows) and it is
also found at the rim of transverse sections of WPBs (arrowheads) near the
Golgi. (h) An electron-dense coat that is labeled with an AP-1 antibody
(arrowhead) is associated with an elongated VWF-containing structure. 
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interfering RNA (siRNA) against the 
 
 
 
1 subunit of the AP-1
complex (Hirst et al., 2003). Consistent with the fact that the in-
complete AP-1 complex in 
 
 
 
1A-deficient cells cannot be re-
cruited onto membranes (Meyer et al., 2000), the 
 
 
 
 subunit of
AP-1 became cytosolic when 
 
 
 
1 was knocked down by RNAi
(Fig. 3 e). Two rounds of siRNA treatment were required for ef-
ficient knockdown, giving a knockdown level of 
 
 
 
90%, as as-
sessed by real-time PCR. As shown in Fig. 3 (e and f), AP-1
knockdown caused a failure in the formation of WPBs and was
effectively a phenocopy of the effect of AP180-C transfection
(Fig. 3 b), strongly suggesting that clathrin and AP-1 are in-
volved in the same process. The specificity of the effect is illus-
trated by the fact that WPBs were still observed in VWF-trans-
fected HEK293 cells (Fig. 3 j) when another clathrin-associated
adaptor complex, AP-3, was depleted 90% by RNAi.
As with the AP180-C experiments, AP-1 knockdown
caused an increase in the appearance of fine puncta in both
HEK293 cells (Fig. 3 f) and HUVECs (Fig. 3 l). The latter also
shows an example of the accumulation of VWF within pericen-
Figure 3. Clathrin and AP-1 are required for WPB biogenesis. (a and b)
HEK293 cells were cotransfected with AP180-C and full-length VWF con-
structs. WPB formation was impaired in a cell transfected with AP180-C.
In contrast, elongated WPBs were clearly seen in a cell that did not con-
tain AP180-C (*). (c–j) The depletion of AP-1, but not AP-3, impairs the
formation of WPBs in HEK293 cells. Cells were transfected with a full-
length VWF construct and AP-1 siRNA (e and f), AP-3 siRNA (i and j), or
mock transfected (c, d, g, and h). Although elongated WPBs were clearly
observed upon AP-3 RNAi (j), WPBs formation was severely impaired
upon AP-1 siRNA treatment (f). (k and l) Similar results were obtained in
HUVECs. Elongated WPBs are abundant in a mock-treated cell (k) but not
in the AP-1–depleted cell (l). Insets show a magnified view of the boxed
regions. Bars, 10  m.
Figure 4. AP180-C and AP-1 RNAi cause a significant reduction in PMA-
stimulated VWF secretion, which is not the result from the loss of TGN
integrity nor from furin missorting. (a) HEK293 cells were cotransfected
with a full-length VWF construct and AP180-C (white bars) or a control
vector (gray bars). VWF secretion assays were performed 2–3 d after
transfection. The PMA-responsive pool of VWF was estimated by subtracting
the amount of VWF released from constitutive secretion from that released
upon PMA addition. All data were normalized using the total signal of
VWF (see Materials and methods). Each bar represents the mean   SD,
n   3. (b and c) HEK293 cells were transfected with an siRNA targeted at
the  1 subunit of the AP-1 complex. After 3 d, the cells were further trans-
fected with the same siRNA together with a full-length VWF construct (b) or
an ssHRP construct (c). Secretion assays were performed 2–3 d after the
second transfection. Although stimulated secretion of VWF was abolished,
constitutive secretion of transfected ssHRP was not impaired in AP-1–
depleted cells, suggesting the integrity of the TGN. The gray bars represent
data from mock transfection, whereas the white bars represent data from
the AP-1 RNAi. Each bar represents the mean   SD, n   4. *, see section
Clathrin and AP-1 are essential for WPB biogenesis. (d) Cotransfection of
the propeptide and mature VWF constructs failed to rescue the defect
in regulated secretion in AP-1–depleted cells. Each bar represents the
mean   SD, n   5. (e) Cotransfection with two VWF constructs containing the
pro-region and the mature region, respectively, generated WPBs in control
HEK293 cells. The cells were labeled with rabbit anti-VWF, followed by
Texas red–conjugated donkey anti–rabbit secondary antibodies. Inset
shows the magnified view of the boxed region. Bar, 10  m. 
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triolar structures that is occasionally seen. ELISA-based VWF
secretion assays in HEK293 showed that upon AP-1 RNAi,
secretagogue-stimulated secretion of VWF was completely
abolished (Fig. 4 b). This is in line with the failure of AP-1
knockdown cells to make WPBs. We also found that, as with the
AP180-C experiments, there was an increase in constitutive se-
cretion of VWF (Fig. 4 b). This increase may explain the nega-
tive value of stimulated VWF secretion in Fig. 4 b (asterisk), as
it was calculated by subtracting the amount of VWF secreted
constitutively from that secreted in a regulated manner. In sum-
mary, removal of clathrin or AP-1 by AP180-C expression or
siRNA, respectively, gave rise to a very similar phenotype, sug-
gesting that they work at the same step in WPB biogenesis.
 
Defective WPB biogenesis does not 
reflect loss of TGN integrity nor furin 
missorting
 
When AP-1 was depleted, the regulated exocytosis of VWF
was significantly reduced in parallel with the failure of WPB
formation. However, the increase in constitutive secretion did
not fully compensate for the drop in regulated secretion (Fig. 4
b). This raised the question of whether AP-1 depletion signifi-
cantly affects the general structure of the TGN and impairs all
the secretory pathways, thereby causing the failure in WPB
formation. To test the functional integrity of the TGN, we co-
transfected HEK293 cells with AP-1 siRNA and cDNA en-
coding the constitutive secretory marker signal sequence HRP
(ssHRP; Connolly et al., 1994) and confirmed that the constitu-
tive secretory pathway was not impaired (Fig. 4 c). In addition,
we did not find a difference in the TGN at the light microscopy
level by TGN46 immunolabeling in mock-transfected and AP-
1–depleted HEK293 and HUVECs (Fig. S1, b–e, available at
http://www.jcb.org/cgi/content/full/jcb.200503054/DC1). Our
results therefore suggest that the TGN in AP-1–depleted cells
remains fully capable of AP-1–independent functions. Consis-
tent with our findings, it has been reported that cytosol depleted
of ARF1, which is required for membrane recruitment of AP-1,
is still able to support HA secretion in a permeabilized cell as-
say (Ellis et al., 2004). Together, we conclude that the failure
of WPB formation in AP-1 knockdown cells is not caused by a
general breakdown in TGN function.
As it passes through the trans-Golgi, pro-VWF is thought
to be cleaved by furin to generate a propeptide of 741 aa and a
mature protein of 2,050 aa (Creemers et al., 1993). Furin is lo-
calized to the TGN at steady state (for review see Thomas,
2002) but cycles through endosomes and the plasma mem-
brane, and in 
 
 
 
1A-deficient fibroblasts, furin is missorted
(Folsch et al., 2001) to endosomes. Indeed, we found that VWF
cleavage was impaired in AP-1–depleted cells (Fig. S1 a).
Whether furin cleavage is required for VWF storage in WPBs
is not clear, as a VWF construct with a mutated furin cleavage
site retains the ability to generate WPBs in CV-1 cells (Voor-
berg et al., 1993) but not in RIN5F cells (Journet et al., 1993).
We find that there is an additional effect of AP-1 depletion in-
dependent of furin cleavage of VWF. We presented cells with a
“pre-cleaved” form of VWF by coexpressing in trans the VWF
propeptide and the mature VWF from separate constructs
(Haberichter et al., 2000). As shown in Fig. 4 e, the coexpres-
sion of these two components results in normal WPB biogene-
sis (Haberichter et al., 2000; unpublished data). If the defect in
WPB biogenesis that we observed in AP-1 knockdown cells is
solely due to the missorting of furin, the precleaved VWF
should rescue the wild-type VWF phenotype in Fig. 4 b. Im-
portantly, the introduction of precleaved VWF did not rescue
Figure 5. The AP-1/clathrin coat is involved in an early
stage of WPB biogenesis, but not in the maintenance of the
cigar shape of preformed WPBs. (a and b) A BFA-sensitive
coat is not required for the maintenance of the shape of existing
WPBs. HUVECs were treated with 5  g/ml BFA for 30 min
(b). Compared with untreated cells in panel a, there was no
significant change to the appearance in anti-VWF staining.
(c) Anti– -adaptin staining shows that AP-1 dissociates from
WPBs and other membranes upon BFA treatment. (d–f)
HUVECs were treated with 10  M of monensin for 1 h (see
Fig. S2), nucleofected with GFP-VWF, and allowed to recover
overnight. The cells were labeled with rabbit anti-VWF (d),
followed by Texas red–conjugated anti–rabbit antibody.
Although the old rounded WPBs did not return to the original
shape, newly synthesized WPBs had a classic rod shape (e).
(g–l) HUVECs were microinjected with GFP-VWF together
with a control vector plasmid (g–i) or AP180-C (j–l), fixed 16 h
later, and labeled with anti-VWF (g and j; blue in i and l) and
anti-GFP (h and k; green in i and l). Although old WPBs re-
mained clearly visible in both cases, the cell microinjected
with AP180-C failed to make new cigar-shaped WPBs. (insets)
Anti-myc labeling shows the microinjected AP180-C construct.
Bars, 10  m. 
JCB • VOLUME 170 • NUMBER 4 • 2005 632
 
the AP-1 knockdown phenotype (Fig. 4 d). The PMA-sensitive
pool of VWF in AP-1 knockdown cells transfected with pre-
cleaved VWF remained negligible compared with that of the
control cells. In addition, cell counting revealed that AP-1
knockdown on cells expressing precleaved VWF reduced the
number of cells that contained cigar-shaped WPBs by three-
fold, and the number of WPBs in cells that had any WPBs at all
was also reduced. Similarly, the precleaved VWF could not
rescue the AP180-C phenotype (unpublished data). In conclu-
sion, the defect in WPB biogenesis in AP-1 knockdown and
AP180-C–transfected cells could not be simply explained by
furin missorting. AP-1 and clathrin must therefore have an ad-
ditional role in WPB biogenesis.
 
Site of action and role of the coat
 
The localization of the clathrin/AP-1–coated WPBs and the fact
that AP-1 knockdown and the overexpression of AP180-C
abolish the formation of WPBs instead of affecting their matu-
ration strongly suggest that the coat is acting to facilitate the ini-
tial formation of these organelles. To test if maintenance of the
distinctive shape of existing WPBs is also coat dependent, we
exploited the fact that a brief brefeldin A (BFA) treatment of
cells causes ARF1-dependent coats, such as AP-1, AP-3, AP-4,
and GGAs (Golgi-associated 
 
 
 
-ear-containing ARF-binding
proteins), to dissociate from the membranes (Nie et al., 2003;
Robinson, 2004). We tested whether a BFA-sensitive coat is re-
quired for maintaining the elongated shape of WPBs. HUVECs
were treated with 5 
 
 
 
g/ml BFA for 2 min, after which the AP-1
complex was no longer membrane associated (Robinson and
Kreis, 1992). There was no difference in the appearance of
WPBs before and after BFA treatment, suggesting that, once a
WPB is formed, the elongated shape can be maintained in the
absence of a BFA-sensitive coat. Longer BFA incubations of 30
min also led to the same conclusion (Fig. 5, b and c).
Clathrin and AP-1 therefore appear to act early during the
formation of WPBs. If the machinery of which these compo-
nents are a part operates exclusively at an early stage of WPB
biogenesis, then perturbation of WPB structure after budding
from the TGN should be irreversible. We used monensin, an
ionophore that perturbs the pH of organelles, to change the
elongated WPBs to round structures (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200503054/DC1). Cells were
then nucleofected with GFP-VWF and allowed to recover in
monensin-free medium overnight (Fig. 5, d–f). The alter-
ation in shape is irreversible because the rounded WPBs did
not return to their original rod shape, whereas newly formed
GFP-VWF–containing WPBs (Fig. 5 e) were a classic cigar
shape. This result strongly implies that a critical event occurs
during the initial stages of WPB biogenesis to form the elon-
gated structure. Taking into account the prominence of coated
WPBs in the perinuclear region and the effects of AP180-C and
AP-1 RNAi on WPB biogenesis, we predict that clathrin and
AP-1 are essential to the mechanism of this critical event that
forms the cigar shape.
Our data suggest that although the clathrin/AP-1 coat is
essential to the initial formation of WPB at the perinuclear re-
gion, it is not necessary to maintain the cigar shape once it is
completely formed. As an independent confirmation of this, we
microinjected HUVECs with a GFP-VWF construct to allow
observation of the formation of new WPBs. At 16 h after mi-
croinjection, GFP-VWF expressed alone was clearly visible
within cigar-shaped WPBs (Fig. 5 h). In 40 cells microinjected
so as to express both AP180-C and GFP-VWF, we found no
green WPBs but only fine puncta (Fig. 5 k), consistent with the
results from HEK293 cells (Fig. 3 b). In this experiment, the
accumulation of GFP-VWF is more obvious than in Fig. 3 b,
probably due to the overexpression of GFP-VWF after micro-
injection. In this system, mature endogenous WPBs were iden-
tified by the presence of anti-VWF labeling coupled to a lack
of GFP-VWF. In cells microinjected with AP180-C, mature
elongated WPBs were still abundant (Fig. 5 j), confirming that
clathrin is not required for the maintenance of WPBs, consis-
tent with the BFA experiment (Fig. 5, a–c).
 
Failure in the recruitment of WPB 
components
 
AP-1–depleted cells lose the ability to generate elongated
WPBs but generate fine VWF-positive puncta. These structures
are not simply miniature WPBs because they do not have the
ability to undergo regulated exocytosis. This loss suggests that
they may also have an altered membrane composition. We
therefore tested the ability of the VWF-positive puncta to re-
cruit two WPBs membrane components, Rab27a and P-selec-
tin. In AP-1–depleted HUVECs, GFP-Rab27a and P-selectin
failed to be recruited onto the VWF-positive puncta (Fig. 6, d
and h). GFP-Rab27a became cytosolic (Fig. 6 d), whereas
Figure 6. VWF-positive puncta in AP-1–depleted HUVECs cannot recruit
WPB components. (a–d) GFP-Rab27a was recruited onto peripheral WPBs
in mock-transfected cells (b), but upon AP-1 RNAi, became cytosolic (d)
and failed to associate with the VWF-positive puncta (c). (e–h) HUVECs
were treated with 100  M leupeptin and 100  M pepstatin for 6 h before
fixation. The colocalization of P-selectin and VWF (e and f) was lost upon
AP-1 RNAi (g and h). P-selectin was observed only after the lysosomal
inhibitor treatment (h), suggesting that it was targeted to lysosomes for
degradation in the absence of WPBs in AP-1–depleted cells. Bar, 10  m. 
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P-selectin was only observed after the addition of lysosomal in-
hibitors (Fig. 6 h), suggesting that it was delivered to endoso-
mal/lysosomal compartments for degradation. Similar results
were obtained in HEK293 cells (unpublished data). In contrast,
VWF mutated such that it can no longer form cigar-shaped
WPBs is still capable of recruiting these membrane proteins
(Michaux et al., 2003). This implies a fundamental change in
the VWF that is made in the absence of AP-1/clathrin.
 
Discussion
 
We have discovered that WPBs are extensively coated. We have
determined by EM and immunofluorescence that this coat in-
cludes clathrin and AP-1. We found that where coat function
is experimentally prevented, cigar-shaped WPBs cannot be
formed but that instead small VWF-positive puncta can be seen.
Furthermore, there is a failure to recruit WPB membrane pro-
teins and regulated secretion of VWF is significantly reduced.
Interference with the ability of either clathrin or AP-1 to func-
tion has the same effect. Thus, we conclude that AP-1 and clath-
rin play a key role in a fundamental stage of WPB biogenesis.
There have been reports of extensive clathrin lattices on
other intracellular organelles including stage I melanosomes
(Raposo et al., 2001) and early vacuolar endosomes (Raiborg et
al., 2001; Sachse et al., 2002). Melanosomes, like WPBs, are ly-
sosome-related organelles, but not much is known about the coat
on stage I melanosomes. The endosomal coat contains the clath-
rin-interacting protein Hrs (hepatocyte growth factor-regulated
tyrosine kinase substrate), which binds, sequesters, and concen-
trates ubiquitinated receptors such as EGFR on the outer mem-
brane of the endosomes (Raiborg et al., 2002; Sachse et al.,
2002). However, unlike the endosomal coat, the coat on WPBs
does not appear bilayered (Fig. 2 h). In addition, the endosomal
coat does not contain AP-1 (Sachse et al., 2002), whereas GFP-
Hrs does not localize to WPBs (unpublished data), suggesting
different modes of action of these two clathrin coats.
 
Coat function on WPBs
 
Clathrin and AP adaptor protein complexes mediate transport
between subcellular compartments by forming small vesicular
carriers. For instance, AP-2 CCVs are responsible for internal-
ization of many receptors from the plasma membrane, whereas
AP-1 CCVs are involved in vesicular transport between the
TGN and endosomes. How does this relate to their appearance
on a forming secretory granule at the TGN? Within forming
WPBs, extra membrane has to be delivered as the WPB length-
ens. The extensive coating could in principle somehow reflect
the footprint of CCV delivering membrane to a forming WPB.
This seems unlikely because new membrane is more likely to
originate from within the TGN from which the WPB is bud-
ding, and also it has long been believed that CCVs have to be
uncoated before they can fuse to target membranes (Ungewick-
ell et al., 1995). Although a more recent study suggests that tu-
bules partially coated with AP-1 may fuse with each other
(Waguri et al., 2003) it does appear that a significant area of the
fusion front is devoid of AP-1. Finally, judging by the degree
of coating on WPBs in our electron micrographs, we conclude
that it does not represent CCVs fused to WPBs because we
would have to postulate that in addition to keeping their coat
during fusion, the membrane would have to retain it after fu-
sion.
By analogy to ISG formation (Dittie et al., 1997;
Klumperman et al., 1998), we would expect that clathrin and
AP-1 would participate in the retrieval of missorted proteins
from immature WPBs. We have seen occasional coated budding
profiles on WPBs by conventional EM (Fig. S3 b) that would be
consistent with this maturation pathway. However, it is clear
that this is not the sole function of coat proteins in WPB biogen-
esis because upon AP-1 RNAi we observed no WPBs rather
than immature WPBs containing missorted proteins, indicating
that WPB formation was blocked at an earlier stage. A more
novel possibility is that the small budding profiles represent the
removal of proteins or lipids that bend membranes, hereby con-
tributing to the shaping of WPBs. However, a failure in this
function should lead to the appearance of large, rounded WPBs.
Finally, these buds might reflect the removal of channels or
transporters that control the profolding milieu of the immature
WPBs for VWF. That this environment is important is shown by
the monensin data. However, a failure in such a function would
also presumably lead to WPBs more like those seen after mo-
nensin, rather than the small puncta that we observed.
Another possible function of the coat that we considered
was that the clathrin acts as a simple “corset” for WPBs; i.e., it
facilitates the elongation of WPBs by acting as a mechanical
shaping device during formation. This hypothesis derives from
a simple consideration of the content of WPBs; i.e., the long
proteinaceous tubules made from VWF that fill its interior. We
wondered whether their parallel stacking along the long axis of
the WPBs resulted from the constraining influence of a corset.
However, this hypothesis, although attractive, is not consistent
with the effects of losing the coat. Loss of a simple corset
should lead to a large rotund WPBs (as produced by monensin
treatment) rather than altogether losing the ability to bud a
large VWF-positive structure.
In general, secretory granules form around their dense
protein cores, which are made by selective aggregation within
the TGN (Arvan and Castle, 1998; Tooze et al., 2001). The
membranes of these roughly spherical organelles are not exten-
sively coated and their biogenesis is seen as largely content
driven; expression of granule content proteins can lead to the
formation of dense-cored secretory granules de novo. Why are
WPBs different? The most obvious difference between WPBs
and conventional granules is that they are not round, but long
cylinders. This structure is not likely to be a low-energy shape,
and presumably requires some scaffolding to construct. We
therefore propose a model in which the extensive coating some-
how stabilizes the forming WPBs, perhaps allowing time for
folding of its contents into the protein tubules characteristic of
the WPBs, maybe even blocking its premature scission. The loss
of such a scaffold would thus lead to a failure to make any ob-
ject even closely resembling the WPBs, but instead to the for-
mation of smaller puncta. Interestingly, although VWF secre-
tion partially switches to constitutive release, not all of the
protein does so. VWF is unusually able to drive the formation of 
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its own specialized carrier; even in cells with a regulated path-
way, VWF is not targeted to the endogenous secretory granules
but drives the formation of pseudo-WPBs instead (Wagner et
al., 1991). It may therefore have an intrinsic tendency to avoid
constitutive secretion. That losing the coat prevents the initial
formation of the cigar strongly suggests that the coat is needed
for allowing the contents to somehow drive the formation of its
shape. This is supported by the results of the monensin experi-
ment. We find that monensin treatment causes WPBs to become
spherical, but that after removal of the drug, the treated WPBs
cannot regain their cigar shape. This implies that shape forma-
tion is coupled to biogenesis, and thus to the coat because new
WPBs form at the TGN where we see them coated.
The VWF-positive puncta in AP-1–depleted cells failed
to recruit P-selectin or Rab27. Because it has been reported that
P-selectin does not bind AP-1 (Daugherty et al., 2001), we
speculate that the suggested prevention of premature scission
by a scaffold provides more time for efficient recruitment of
P-selectin and/or allows VWF to be processed to a configuration
that somehow leads to the recruitment of membrane proteins.
Because Rab27a is only recruited to mature WPBs (Hannah et
al., 2003), the first mechanism is not possible for this protein. It
should be noted that heterologous expression of VWF in
HEK293 cells causes the recruitment of Rab27a, CD63, and
P-selectin onto pseudo-WPBs (Michaux et al., 2003), suggest-
ing that lumenal VWF can somehow drive the recruitment of
proteins on the other side of the membrane.
In this paper, we present the first evidence that AP-1 and
clathrin are essential to the initial steps of biogenesis of a regu-
lated secretory organelle. AP-1 is known to interact with sev-
eral accessory proteins, such as 
 
 
 
-synergin and epsinR (Page et
al., 1999; Kalthoff et al., 2002; Wasiak et al., 2002; Hirst et al.,
2003; Mills et al., 2003). To form WPBs, it is possible that a
different set of effectors, which remain to be identified, are re-
quired. Unlike other secretory granules, we show that cargo ag-
gregation alone is not sufficient to form immature WPBs. We
propose that the AP-1/clathrin coat forms a stabilizing scaffold
that is essential to the formation of these very large organelles
and is not acting in organelle formation via small vesicles.
Therefore, we have unveiled a novel mode of action for this
AP-1–associated clathrin coat.
 
Materials and methods
 
Chemicals and antibodies
 
All chemicals were purchased from Sigma-Aldrich or BDH unless other-
wise stated. Rabbit antibody against the 
 
 
 
 subunit of AP-3 and mouse
mAb against VWF propeptide (239.1) were gifts of M.S. Robinson (Cam-
bridge Institute for Medical Research, Cambridge, UK; Simpson et al.,
1997) and S.L. Haberichter (Medical College of Wisconsin, Milwaukee,
WI; Haberichter et al., 2000), respectively. mAbs against 
 
 
 
-adaptin (mAb
100/3) and AP180 were purchased from Sigma-Aldrich. Mouse mono-
clonal anti-clathrin (clone X22) and anti-myc (9E10) were purchased from
Abcam and Santa Cruz Biotechnology, Inc., respectively. Rabbit poly-
clonal anti-VWF and its HRP-conjugated form were obtained from Dako-
Cytomation. Sheep polyclonal anti-VWF and anti-TGN46 were supplied
by Serotec. Texas red–, FITC-, and Cy5-conjugated secondary antibodies
were purchased from The Jackson Laboratory.
 
Expression vector constructs
 
The construct expressing the COOH terminus of AP180 (AP180-C) was a
gift of H.T. McMahon (Medical Research Council Laboratory of Molecular
Biology, Cambridge, UK; Ford et al., 2001). The full-length human VWF
construct in pCI-neo (Michaux et al., 2003) and ssHRP construct (Connolly
et al., 1994) have been described previously. The human VWF propeptide
(VWFpp) and mature VWF construct (
 
 
 
pro) constructs were gifts from S.L.
Haberichter (Haberichter et al., 2000). GFP-VWF (Romani de Wit et al.,
2003), GFP-Hrs (Urbe et al., 2003), and GFP-Rab27a (Hume et al., 2001)
were provided by J. Voorberg and J.A. Van Mourik (Sanquin Research at
CLB, , Amsterdam, Netherlands), S. Urbé (University of Liverpool, Liverpool,
UK), and M.C. Seabra (Imperial College London, London, UK), respectively.
 
EM
 
HUVECs were grown on 6-cm Petri dishes (for embedding pellets) or cov-
erslips (for embedding en face) and processed for conventional EM as
previously described (Michaux et al., 2003). In brief, the cells were fixed
with 2% PFA/1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer
and then treated with 1% osmium tetroxide/ 1.5% potassium ferricyanide,
followed by 1% tannic acid. The samples were processed for conventional
embedding in epon. Ultrathin 60-nm sections were stained with lead ci-
trate and observed with a transmission electron microscope (model Philips
EM420; FEI UK).
For immuno-EM of cryosections, HUVECs were fixed with 4% PFA in
0.1 M sodium phosphate buffer, pH 7.4 (PB), for 30 min at 37
 
 
 
C. Cells
were washed in PB, and excess aldehyde was quenched using 50 mM gly-
cine/PB. Cells were embedded in 12% gelatin, cryoprotected in 2.3 M su-
crose at 4
 
 
 
C overnight, and frozen in liquid nitrogen as previously described
(Raposo et al., 1997). Ultrathin cryosections were cut using an Ultracut FCS
microtome (Leica) and picked up in a 1:1 mixture of 2% methylcellulose and
2.3 M sucrose. Cells were single labeled with either a mAb against 
 
 
 
-adap-
tin (mAb100/3; Sigma-Aldrich) or a rabbit polyclonal antibody against
VWF (DakoCytomation). Sections were quenched in 50 mM glycine/50
mM NH
 
4
 
Cl, labeled with primary antibody in 1% BSA/0.5% BSA-C (Au-
rion), and detected with 10-nm gold particles conjugated to protein A (PAG;
obtained from J.W. Slot, Utrecht University, Utrecht, Netherlands). Where
the primary antibody was a monoclonal, a rabbit anti–mouse bridging anti-
body (DakoCytomation) was used before the PAG. Cells were also double
labeled with anti–
 
 
 
-adaptin followed by a rabbit anti–mouse bridging anti-
body and 5 nm PAG. 1% glutaraldehyde was used to prevent recognition of
the intermediate antibody by the secondary gold, before quenching and la-
beling with anti-VWF and 15 nm PAG. All sections were contrast stained
and supported in a mixture of methylcellulose and uranyl acetate before be-
ing imaged with a transmission electron microscope.
 
Tissue culture and transfection
 
HEK293 cells were obtained from BD Biosciences and were maintained in
 
 
 
-MEM medium (GIBCO BRL) with glutamax, 10% FCS (Sigma-Aldrich),
and 50 
 
 
 
g/ml gentamicin (GIBCO BRL). HUVECs were purchased from
TCS-Cellworks and were grown in HUVEC growth medium, which con-
tains M199 medium with Earle’s modified salts (GIBCO BRL), 20% FCS,
10 U/ml heparin (Sigma-Aldrich), 30 
 
 
 
g/ml endothelial growth supple-
ment (Sigma-Aldrich), and 50 
 
 
 
g/ml gentamicin as previously described
(Arribas and Cutler, 2000). For the monensin treatment, HUVECs were in-
cubated with 10 
 
 
 
M monensin in HUVEC growth medium for 1 h at 37
 
 
 
C.
For the BFA treatment, HUVECs were treated with 5 
 
 
 
g/ml BFA for 2, 10,
or 30 min at 37
 
 
 
C before being processed for immunofluorescence.
Nucleofection (Amaxa) was used to transfect DNA and siRNA into
tissue culture cells, according to the supplier’s instructions. Typical trans-
fection rate is 30–70%. For microinjection, 0.1 
 
 
 
g/
 
 
 
l DNA was injected
together with biotin-dextran into the nuclei of 
 
 
 
50 cells over a period of
20 min.
 
RNAi
 
The siRNA directed against the 
 
 
 
1 subunit of AP-1 has been described
previously (Hirst et al., 2003). siRNA against the 
 
 
 
3A subunit of AP-3 was
purchased from QIAGEN and the target sequence is ATGGCTGATCT-
TGAAGGTTTA. Cells were transfected with 300–600 pmol of siRNA by
nucleofection (Amaxa) using the nucleofection program A-23 for HEK293
or program U-01 for HUVECs. Typically, a 15-cm Petri dish of cells that
are 70–80% confluent were used for four to six nucleofection reactions.
Two reactions were plated onto each 9-cm Petri dish and incubated for
2–3 d at 37
 
 
 
C. The cells were then nucleofected again with 4 
 
 
 
g of a full-
length VWF DNA construct (Michaux et al., 2003) and 150–300 pmol of
siRNA, and incubated for 3 d before being processed for immunofluores-
cence and secretion assays.
 
Immunofluorescence
 
Tissue culture cells grown on coverslips were fixed with 3% PFA,
quenched, and permeabilized with 50 mM NH
 
4
 
Cl and 0.2% saponin. 
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After blocking in PGAS (PBS, 0.2% gelatin, 0.02% NaN
 
3
 
, and 0.02%
saponin), the cells were incubated with primary antibodies for 45 min,
washed in PGAS, followed by a 45-min incubation with fluorophore-
conjugated secondary antibodies. The coverslips were washed in PGAS
and mounted with ProLong antifade reagent (Molecular Probes). The im-
age in Fig. 4 e was acquired using an Orca CCD camera (Hamamatsu)
and Improvision Openlab software through a 63
 
 
 
 oil immersion lens
(NA 1.4) on a microscope (model Axioskop; Carl Zeiss MicroImaging,
Inc.). All other coverslips were examined at ambient temperature
through a 60
 
 
 
 oil immersion lens (NA 1.4) on a microscope (model
Optiphot 2; Nikon) fitted with a confocal laser scanner (model MRC
1024; Bio-Rad Laboratories) unless stated otherwise. Lasersharp (Bio-
Rad Laboratories) was the image acquisition program used; Adobe
Photoshop 6.0.1 and Illustrator 10 were used to generate figures from
digital images.
 
Secretion assays
 
Stimulated VWF secretion in transfected HEK cells was performed as previ-
ously described (Michaux et al., 2003). Cells were rinsed in the release
medium (
 
 
 
-MEM with glutamax, 10 mM Hepes, pH 7.4, and 0.2% BSA)
and 1.5 ml of release medium was put in each well for the 30-min consti-
tutive secretion. The cells were incubated with 1.5 ml of release medium
containing 100 ng/ml PMA for 30 min of stimulated secretion at 37
 
 
 
C.
Medium was collected after each 30-min incubation. The remaining VWF
was released by cell lysis at 4
 
 
 
C for 30 min in the lysis medium (release
medium containing 0.5% vol/vol Triton X-100, 1 mM EDTA, and protease
inhibitors). The relative amounts of VWF were quantified by ELISA as de-
scribed previously (Blagoveshchenskaya et al., 2002). The level of secre-
tion was normalized by the total amount of VWF, which was calculated
by adding all the signals from the constitutive and stimulated secretions as
well as the remaining VWF after secretions.
For the ssHRP secretion assays in HEK293 cells, an ssHRP construct
(Connolly et al., 1994) was cotransfected during the second round of
siRNA nucleofection. 2 d after the nucleofection, the cells were rinsed
twice with the normal HEK293 growth medium. 1.5 ml of medium was put
in each well and constitutive secretion of ssHRP was allowed to occur for
6 h at 37
 
 
 
C. The cells were then lysed as described in the previous para-
graph to release the intracellular ssHRP left behind. HRP activity was mea-
sured using an 
 
o
 
-phenylenediamine assay in which 100 
 
 
 
l of sample was
incubated with an equal volume of assay buffer (39.2 mM citric acid,
132.4 mM dibasic sodium phosphate, 0.1% vol/vol Triton X-100, 0.1%
vol/vol H
 
2
 
O
 
2
 
, and 0.6% vol/vol saturated 
 
o
 
-phenylenediamine) for 15
min at RT in a 96-well plate. The reaction was stopped by adding 50 
 
 
 
l of
3 M HCl and the plate was read at 490 nm. The data were expressed as
a ratio of constitutively secreted to intracellular ssHRP.
 
Real-time PCR
 
RNA was prepared from tissue culture cells using QIAshredder (QIAGEN)
and RNeasy mini kit (QIAGEN) according to the manufacturer’s instruc-
tions. The RNA was then subjected to reverse transcription using Super-
Script III first-strand cDNA synthesis system (Invitrogen). Real-time PCR was
carried out in a DNA Engine Opticon 2 system (MJ Research) using Dy-
NAmo SYBR green qPCR kit (Finnzymes). The C(T) data were normalized
with a GAPDH internal control and analyzed using the 2
 
   
 
C(T)
 
 method (Li-
vak and Schmittgen, 2001). The primers used for GAPDH amplification
were 5
 
 
 
-CAGCCTCAAGATCATCAGCA-3
 
 
 
 and 5
 
 
 
-GTCTTCTGGGTG-
GCAGTGAT-3
 
 
 
. For 
 
 
 
1 PCR, the primers 5
 
 
 
-CTAGTGTGGAGGCCGAA-
GAC-3
 
 
 
 and 5
 
 
 
-CGGAGCTGGTAATCTCCATT-3
 
 
 
 were used.
Online supplemental material
Fig. S1 shows the impaired VWF cleavage and intact TGN morphology in
AP-1–depleted cells, whereas Fig. S2 shows the effect of monensin on the
shape of WPBs. Additional electron micrographs of WPBs can be found in
Fig. S3. The online supplemental material is available at http://www.
jcb.org/cgi/content/full/jcb.200503054/DC1.
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